IP Verse

Novartis Pharmaceuticals competitive analysis

Latest PTAB cases involving Novartis Pharmaceuticals

Discover the latest PTAB cases involving Novartis Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novartis Pharmaceuticals

IPR2023-01346Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANFinal Written Decision - Appealed
IPR2023-01347Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANTerminated-Adverse Judgment
IPR2022-00886Apr 20, 2022NOVARTIS PHARMACEUTICALSSHILPA PHARMAFinal Written Decision - Appealed
IPR2020-01263Aug 7, 2020BIOCON PHARMANOVARTIS PHARMACEUTICALSInstitution Denied
IPR2018-01287Jun 18, 2018NOVARTIS PHARMACEUTICALSPLEXXIKONInstitution Denied
IPR2018-00507Jan 17, 2018HIKMA PHARMACEUTICALSNOVARTIS PHARMACEUTICALSTerminated-Settled
IPR2017-01929Aug 16, 2017SUN PHARMACEUTICAL INDUSTRIESNOVARTIS PHARMACEUTICALSTerminated
IPR2017-01946Aug 15, 2017ACTAVIS ELIZABETHNOVARTIS PHARMACEUTICALSFinal Written Decision
IPR2017-01592Jun 12, 2017BRECKENRIDGE PHARMACEUTIALNOVARTIS PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Novartis Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NOVARTIS PHARMACEUTICALS - - 45
BIOCON PHARMA - - 1 -
BRECKENRIDGE PHARMACEUTIAL - - 1 -
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - 1 - 6